Skip to main content

"We've detected that you're visiting from {0}. Would you like to switch languages for tailored content?"

->

Restrata™ Matrix is now indicated for use with Solventum™ V.A.C. ® Therapy*

Clearance pairs innovative synthetic electrospun fiber matrix technology with industry-leading negative pressure wound therapy to optimize healing.

Contact us
Blue gloved hand holding a sheet of Restrata electrospun fiber matrix displayed alongside VAC negative pressure wound therapy systems in a hospital operating room setting.

Two advanced technologies. One path for active healing.

Restrata™ Synthetic Electrospun Fiber Matrix

In December 2025, Solventum completed its acquisition of Acera Surgical, expanding its wound care portfolio into synthetic tissue matrices for acute care settings, including Restrata™ Synthetic Electrospun Fiber Matrix. This gives our valued customers more innovative ways to treat complex wounds.

Restrata™ Matrix is the first electrospun, 100% synthetic, fully resorbable matrix engineered to be structurally similar to human extracellular matrix (ECM) and support soft tissue remodeling. It signals the body through structural cues rather than growth factors to create the foundation for soft tissue repair. Built to perform in challenging wound environments, Restrata™ Matrix supports cellular infiltration, neovascularization and organized collagen deposition. It degrades via hydrolysis over time, leaving native tissue behind

Restrata is indicated for:

  • Soft tissue healing: for management of surgical, full-thickness and traumatic wounds
  • Soft tissue reinforcement: for implantation to reinforce soft tissue where weakness exists, in patients requiring soft tissue repair and/or reinforcement

Learn more about Acera
Learn more about Restrata Matrix
Read the press release

*Restrata® Synthetic Electrospun Fiber Matrix Sheet is indicated for use in combination with the Solventum™ V.A.C.® Ulta Therapy Unit and Solventum™ V.A.C.® Peel and Place Dressing and Kit and V.A.C.® Granufoam Dressing and Kit

V.A.C.® Therapy

Meet the most studied NPWT solution — Solventum™ V.A.C.® Therapy. It’s the first commercially available negative pressure wound therapy system and has helped in the treatment of 11 million wounds worldwide.**

It promotes an environment for wound healing by protecting the wound from external contamination, providing a moist wound environment, and helps to:

  • Draw wound edges together
  • Remove exudate and infectious material
  • Reduce edema and promote perfusion
  • Promote granulation tissue formation

**Data on file.

Learn more about V.A.C.® Therapy
Learn more about Solventum™ V.A.C.® Peel and Place Dressing

Solventum and Acera Surgical logos displayed together in a horizontal co-branded layout.

Note: Specific indications, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. Rx only.

"Restrata™ Matrix and V.A.C.® Therapy can succeed even in the most complex wound environments. With Restrata Matrix, I consistently see significant granulation tissue growth within a few days, even in the most challenging cases. Combining Restrata Matrix with V.A.C.® Therapy provides an even greater opportunity to promote healing and improve patient outcomes."


Dr. Luis G. Fernández
M.D., KHS, KCOEG, FACS, FASAS, FCCP, FCCM, FICS
Professor of Surgery at The University of Texas at Tyler
Dr. Luis Fernández is a paid consultant of Solventum

"Complex wounds require clinicians to support tissue repair while also maintaining the right healing environment — this indication brings those needs together in a single approach, giving clinicians another option to support healing more effectively across the course of care.”


Dr. Matthew MacEwan
Ph.D., Chief Science Officer and Co-founder of Acera Surgical
Dr. Matthew MacEwan is a Solventum employee

Contact a Solventum representative to learn more

Complete this form and a Solventum representative will reach out to you soon.

Fields marked with an * are required.

 

Solventum will use the information to respond to your request in accordance with our Privacy Policy. 

There was an error processing your request. Please try again later.